Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Crowther

Showing results (11-20 of 238) with videos related to

Pageof 24
Sort By:
Current Opinion in Hematology|June 25, 2009
A logical approach to surgical thromboprophylaxisKylie Lepic, Mark A Crowther
Polskie Archiwum Medycyny Wewnetrznej|March 28, 2008
Anticoagulation for the prevention of central venous catheter associated-thrombosis: an evidence based commentaryMenaka Pai, Mark A Crowther
Blood|September 29, 2018
Higher-risk APS: do we dare to DOAC?Marissa Laureano, Mark A Crowther
Seminars in Thrombosis and Hemostasis|January 17, 2015
Venous thromboembolism prophylaxis in critically ill patientsKochawan Boonyawat, Mark A Crowther
Journal of the American College of Cardiology|March 10, 2018
Resolving Concerns With the Newer Oral Anticoagulant Medications: Is Hepatotoxicity a Real Concern?Mark A Crowther, Wendy Lim
The New England Journal of Medicine|March 21, 2017
Reduced-Intensity Rivaroxaban for the Prevention of Recurrent Venous ThromboembolismMark A Crowther, Adam Cuker
Current Rheumatology Reports|April 29, 2010
Intensity of warfarin coagulation in the antiphospholipid syndromeMark Crowther, Mark A Crowther
Handbook of Experimental Pharmacology|May 9, 2012
Neutralization of heparin activityMenaka Pai, Mark A Crowther
Current Opinion in Hematology|October 16, 2007
Antiphospholipid antibiodies: a critical review of the literatureWendy Lim, Mark A Crowther
Arteriosclerosis, Thrombosis, and Vascular Biology|June 20, 2015
Antidotes for novel oral anticoagulants: current status and future potentialMark Crowther, Mark A Crowther
Pageof 24

Showing results (11-20 of 238) with videos related to

Sort By:
Pageof 24
Current Opinion in Hematology|June 25, 2009
A logical approach to surgical thromboprophylaxisKylie Lepic, Mark A Crowther
Polskie Archiwum Medycyny Wewnetrznej|March 28, 2008
Anticoagulation for the prevention of central venous catheter associated-thrombosis: an evidence based commentaryMenaka Pai, Mark A Crowther
Blood|September 29, 2018
Higher-risk APS: do we dare to DOAC?Marissa Laureano, Mark A Crowther
Seminars in Thrombosis and Hemostasis|January 17, 2015
Venous thromboembolism prophylaxis in critically ill patientsKochawan Boonyawat, Mark A Crowther
Journal of the American College of Cardiology|March 10, 2018
Resolving Concerns With the Newer Oral Anticoagulant Medications: Is Hepatotoxicity a Real Concern?Mark A Crowther, Wendy Lim
The New England Journal of Medicine|March 21, 2017
Reduced-Intensity Rivaroxaban for the Prevention of Recurrent Venous ThromboembolismMark A Crowther, Adam Cuker
Current Rheumatology Reports|April 29, 2010
Intensity of warfarin coagulation in the antiphospholipid syndromeMark Crowther, Mark A Crowther
Handbook of Experimental Pharmacology|May 9, 2012
Neutralization of heparin activityMenaka Pai, Mark A Crowther
Current Opinion in Hematology|October 16, 2007
Antiphospholipid antibiodies: a critical review of the literatureWendy Lim, Mark A Crowther
Arteriosclerosis, Thrombosis, and Vascular Biology|June 20, 2015
Antidotes for novel oral anticoagulants: current status and future potentialMark Crowther, Mark A Crowther
Pageof 24